Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity - Summary of Non-Vested Options (Detail)

v3.23.1
Stockholders' Equity - Summary of Non-Vested Options (Detail)
3 Months Ended
Feb. 28, 2023
$ / shares
shares
Share-Based Payment Arrangement [Abstract]  
Non-vested at November 30, 2021, Shares | shares 95,486
Granted, Shares | shares 113,000
Vested, Shares | shares (86,843)
Forfeited, Shares | shares 0
Non-vested at February 28, 2022, Shares | shares 121,643
Non-vested at November 30, 2021, Weighted Average Grant-Date Fair Value | $ / shares $ 4.42
Granted, Weighted Average Grant-Date Fair Value | $ / shares 2.19
Vested, Weighted Average Grant-Date Fair Value | $ / shares 3.17
Forfeited, Weighted Average Grant-Date Fair Value | $ / shares 0
Non-vested at February 28, 2022, Weighted Average Grant-Date Fair Value | $ / shares $ 3.24